Stocks
Health Care
cyph
Cypherpunk Technologies
NASDAQ: CYPH
+1.01 (+57.10%)
2.765
USD
At close at Nov 14, 21:40 UTC
Overview
Loading chart...
Key Stats
Market Cap
72.93M
Dividend Yield
0.00%
P/E Ratio
-1.44
EPS
-1.84
Revenue
-
Avg. Volume
160.60M
Recently from Cashu
No Cashu articles
Cypherpunk Technologies currently has no Cashu-related articles
About
What does CYPH do?
Leap Therapeutics, a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, specializes in developing targeted and immuno-oncology therapies for various cancers. Its key candidates include DKN-01 and FL-301, both humanized monoclonal antibodies.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.